218 related articles for article (PubMed ID: 36811166)
1. Radiation-Induced Immunogenic Cell Death for Cancer Radioimmunotherapy.
Liu T; Pei P; Shen W; Hu L; Yang K
Small Methods; 2023 May; 7(5):e2201401. PubMed ID: 36811166
[TBL] [Abstract][Full Text] [Related]
2. EISA in Tandem with ICD to Form In Situ Nanofiber Vaccine for Enhanced Tumor Radioimmunotherapy.
Luo H; Cao H; Jia H; Shang Y; Liu J; Gui H; Yang C; Ren C; Wang Z; Liu J
Adv Healthc Mater; 2023 Oct; 12(27):e2301083. PubMed ID: 37300544
[TBL] [Abstract][Full Text] [Related]
3. Copper-Based Nanoscale Coordination Polymers Augmented Tumor Radioimmunotherapy for Immunogenic Cell Death Induction and T-Cell Infiltration.
Wang Y; Ding Y; Yao D; Dong H; Ji C; Wu J; Hu Y; Yuan A
Small; 2021 Feb; 17(8):e2006231. PubMed ID: 33522120
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic Acid-Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment.
Huang Z; Yao D; Ye Q; Jiang H; Gu R; Ji C; Wu J; Hu Y; Yuan A
ACS Nano; 2021 May; 15(5):8450-8465. PubMed ID: 33938751
[TBL] [Abstract][Full Text] [Related]
5. Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency.
Li Z; Lai X; Fu S; Ren L; Cai H; Zhang H; Gu Z; Ma X; Luo K
Adv Sci (Weinh); 2022 Aug; 9(22):e2201734. PubMed ID: 35652198
[TBL] [Abstract][Full Text] [Related]
6. Integration of radiation and immunotherapy in breast cancer - Treatment implications.
Ye JC; Formenti SC
Breast; 2018 Apr; 38():66-74. PubMed ID: 29253718
[TBL] [Abstract][Full Text] [Related]
7. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy.
Zhang S; Wang J; Kong Z; Sun X; He Z; Sun B; Luo C; Sun J
Biomaterials; 2022 Mar; 282():121433. PubMed ID: 35202933
[TBL] [Abstract][Full Text] [Related]
8. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
[TBL] [Abstract][Full Text] [Related]
9. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
[TBL] [Abstract][Full Text] [Related]
10. Immune modulatory roles of radioimmunotherapy: biological principles and clinical prospects.
Wang X; Wang Y; Zhang Y; Shi H; Liu K; Wang F; Wang Y; Chen H; Shi Y; Wang R
Front Immunol; 2024; 15():1357101. PubMed ID: 38449871
[TBL] [Abstract][Full Text] [Related]
11. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
12. Polymeric Nanosystems for Immunogenic Cell Death-Based Cancer Immunotherapy.
Fu L; Zhou X; He C
Macromol Biosci; 2021 Jul; 21(7):e2100075. PubMed ID: 33885225
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
Esposito A; Criscitiello C; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of Radiotherapy-Induced Immunogenic Cell Death.
Vaes RDW; Hendriks LEL; Vooijs M; De Ruysscher D
Cells; 2021 Apr; 10(4):. PubMed ID: 33920544
[TBL] [Abstract][Full Text] [Related]
15. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death.
Bao X; Xie L
J Exp Clin Cancer Res; 2022 Jul; 41(1):222. PubMed ID: 35836249
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control.
Rodriguez-Ruiz ME; Serrano-Mendioroz I; Garate-Soraluze E; Sánchez-Mateos P; Barrio-Alonso C; Rodríguez López I; Diaz Pascual V; Arbea Moreno L; Alvarez M; Sanmamed MF; Perez-Gracia JL; Escuin-Ordinas H; Quintero M; Melero I
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36631161
[TBL] [Abstract][Full Text] [Related]
17. Immune mechanisms mediating abscopal effects in radioimmunotherapy.
Rodriguez-Ruiz ME; Rodriguez I; Leaman O; López-Campos F; Montero A; Conde AJ; Aristu JJ; Lara P; Calvo FM; Melero I
Pharmacol Ther; 2019 Apr; 196():195-203. PubMed ID: 30529041
[TBL] [Abstract][Full Text] [Related]
18. Cell death induced by cytotoxic CD8
Jaime-Sanchez P; Uranga-Murillo I; Aguilo N; Khouili SC; Arias MA; Sancho D; Pardo J
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32241808
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives.
Aria H; Rezaei M
Biomed Pharmacother; 2023 May; 161():114503. PubMed ID: 36921539
[TBL] [Abstract][Full Text] [Related]
20. [Immunogenic cell death in hematological malignancies].
Matsushita M
Rinsho Ketsueki; 2021; 62(7):709-716. PubMed ID: 34349052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
